Spinal Fractures Clinical Trial
Official title:
Radiographic and Clinical Outcomes Following Non-operative Versus Operative Treatment of AO Type A3 Fractures: A Prospective, Randomized Clinical Trial With an Observational Component
Verified date | January 2017 |
Source | Ohio State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to compare surgery plus bracing versus bracing alone. Both groups are considered standard of care treatments. The goal of this study is to determine which group is a better treatment.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | June 2018 |
Est. primary completion date | June 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. Age 18-65 years 2. Acute trauma patient with AO Type A3.1-A3.3 fractures of T10-L2 3. Neurologically intact 4. TLICS score of 4 5. Women of childbearing potential must have a negative serum pregnancy test Exclusion Criteria: 1. Severe poly-trauma (Injury Severity Score >15 and/or intubation required for > 24 hours) 2. Sepsis and/or organ failure 3. Prior instrumented arthrodesis of the thoracolumbar spine 4. Severe co-morbidities (e.g., heart, respiratory, or renal disease) 5. Recent history (<3 years) of concomitant spinal tumor or infection 6. Greater than single level fracture involvement (other than transverse process fractures) 7. AO Type A3 fracture with associated load sharing score =7 8. = 30 degrees regional kyphosis on standing 9. History of autoimmune (seronegative) spondyloarthropathy (i.e., ankylosing spondylitis) 10. History of osteoporosis 11. Subjects who are pregnant or plan to become pregnant in the next 24 months. Patients will be advised on the use of contraceptives during this time. Methods include abstinence or two acceptable forms including condoms with spermicide, birth control pills, injections, or an IUD. 12. Co-morbidity requiring medication that may interfere with bone or soft tissue healing (i.e., oral or parenteral glucocorticoids, NSAIDs immunosuppressive agents, methotrexate) 13. Severe morbid obesity (BMI > 40) 14. History of metal sensitivity/foreign body sensitivity 15. History of prior laminectomy at the fracture site 16. Associated scoliotic (> 10°) or pre-existing thoracolumbar kyphotic deformity 17. History of substance abuse (recreational drugs, prescription drugs or alcohol) that could interfere with protocol assessments and/or with the subject's ability to complete the protocol required follow-up 18. Prisoner |
Country | Name | City | State |
---|---|---|---|
United States | The Ohio State Unviersity | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
H Francis Farhadi |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compare radiologic outcomes using regional kyphosis and Evaluate clinical outcomes using questionnaires | Primary Outcome is to compare radiologic and clinical outcomes. These will be measured by regional kyphosis, at 2 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients; and Oswestry Disability Index, at 2 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients. | 2 years | |
Secondary | Compare radiologic outcomes using regional kyphosis | Secondary outcome is to compare radiologic outcomes, as measured by regional kyphosis, at 5 and 10 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients | 5 and 10 years | |
Secondary | Evaluate clinical outcomes using questionnaires | Secondary outcome is to evaluate clinical outcomes, as measured by the Oswestry Disability Index, at 5 and 10 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients. | 5 and 10 years | |
Secondary | Compare global sagittal balance at 3 different time points | Secondary Outcome is to compare global sagittal balance at 2, 5, and 10 years. | 2,5, and 10 years | |
Secondary | Collect data on patient in both groups for 10 years | Secondary Outcome is to record frequency and time to secondary surgical intervention among patients in the bracing group. | 10 years | |
Secondary | Compare Return to work rates over a two year peiord | Secondary Outcome is to Compare return-to-work rates at 3 months, 1 year, and 2 years following either non-operative or operative management of thoracolumbar AO type A3.1, A3.2, A3.3 fractures in neurologically-intact patients. | 3 month, 1 year, and 2 years | |
Secondary | Compare Health Care Cost between both groups over 10 years | Secondary Outcome is to compare health care cost and utilization through extended follow-up period. | 10 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02931266 -
PASS MIS® Post-market Clinical Follow-up
|
||
Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
Unknown status |
NCT00290862 -
A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by Osteoporosis
|
N/A | |
Completed |
NCT04956588 -
Evaluation of the Safety and Efficacy of Smart Orthopedic Minimally Invasive Surgical Systems for Spinal Surgery
|
Phase 3 | |
Completed |
NCT04201678 -
Effectiveness of Erector Spinae Block in Kyphoplasty
|
N/A | |
Completed |
NCT02931279 -
PASS OCT® Post-market Clinical Follow-up
|
||
Completed |
NCT02950532 -
Posterior Ligament Complex Assessment Without Magnetic Resonance Image in Thoracolumbar Fractures
|
||
Completed |
NCT02839057 -
Survival After Surgical Treatment of Axis Fractures in Elderly
|
N/A | |
Completed |
NCT02719340 -
Short Segment Fixation in Thoracolumbar Osteoporotic Fracture
|
N/A | |
Completed |
NCT02826889 -
Assessing the Diagnostic Accuracy of Corrected Flow Time (FTc) and Pleth Variability Index (PVI) as Predictors of Fluid Responsiveness in Patients in the Prone Position Using the Jackson Table
|
N/A | |
Recruiting |
NCT02768675 -
Intra-operative Assessment of the Intellirod LOADPRO Spinal Rod Strain Sensor for Use During Kyphotic Corrective Surgery
|
N/A | |
Completed |
NCT00211237 -
CAFE Study - Cancer Patient Fracture Evaluation
|
N/A | |
Recruiting |
NCT02784782 -
Thoracolumbar Burstfractures, Orthesis or No Orthesis
|
Phase 4 | |
Withdrawn |
NCT04325165 -
DBS of PPN to Improve Walking in Chronic SCI Patients
|
N/A | |
Completed |
NCT01123512 -
The Kiva® System as a Vertebral Augmentation Treatment
|
Phase 3 | |
Withdrawn |
NCT00594321 -
Evaluation of Fracture Fixation With Energy and Cement in Tumors of the Spine
|
N/A | |
Not yet recruiting |
NCT02603874 -
The Development of a Vertebra Localizing Aid Medical Device
|
N/A | |
Completed |
NCT01761084 -
Build Better Bones With Exercise
|
N/A | |
Completed |
NCT02840695 -
Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)
|
N/A | |
Completed |
NCT02657265 -
SpineJack® Versus Conservative Treatment Study (SPICO Study)
|
N/A |